Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23777549 | 1.00 | ELANE (0.72) | ELANECTSG | |
| SCHEMBL9435994 | 1.00 | ELANE (0.72) | ELANECTSG | |
| SCHEMBL18880034 | 0.94 | ELANE (0.68) | ELANECTSG | |
| SCHEMBL17378379 | 0.93 | ELANE (0.68) | ELANECTSG | |
| SCHEMBL18880033 | 0.92 | ELANE (0.68) | ELANECTSG | |
| SCHEMBL7284014 | 0.87 | ELANE (0.91) | ELANECTSG | |
| SCHEMBL7437294 | 0.87 | ELANE (0.71) | ELANECTSG | |
| SCHEMBL10577567 | 0.86 | ELANE (0.71) | ELANECTSG | |
| SCHEMBL7285001 | 0.86 | ELANE (0.66) | ELANE | |
| SCHEMBL23969653 | 0.86 | ELANE (0.64) | ELANE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0589937-B1 | USE OF 4-(4-CHLOROPHENYL-SULPHONYLCARBAMOYL) BENZOYL-L-VALYL-L-PROLINE 1(RS)-(1-TRIFLUOROACETYL-2-METHYLPROPYL) AMIDE FOR THE PREPARATION OF A MEDICAMENT FOR THE TREATMENT OF VASCULAR DISEASES | ZENECA LTD (GB) | 2000-03-15 | — | — | EP | claimed |
| US-5338727-A | 4-(4-Chlorophenylsulfonylcarbamoyl)benzoyl-L-valyl-L-proline 1(RS)-(1-trifluoroacetyl-2-methylpropyl)amide or salt | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1994-08-16 | — | — | US | claimed |
| EP-0589937-A1 | USE OF 4-(4-CHLOROPHENYL-SULPHONYLCARBAMOYL) BENZOYL-L-VALYL-L-PROLINE 1($i(RS))-(1-TRIFLUOROACETYL-2-METHYLPROPYL) AMIDE IN THE TREATMENT OF VASCULAR DISEASES | ZENECA LIMITED (GB) | 1994-04-06 | — | — | EP | claimed |
| WO-1992022309-A1 | USE OF 4-(4-CHLOROPHENYL-SULPHONYLCARBAMOYL) BENZOYL-L-VALYL-L-PROLINE 1(RS)-(1-TRIFLUOROACETYL-2-METHYLPROPYL) AMIDE IN THE TREATMENT OF VASCULAR DISEASES | ZENECA LTD. (GB) | 1992-12-23 | — | — | WO | claimed |
| US-5162348-A | 4-(4-chlorophenylsulfonylcarbamoyl)benzoyl-L-valyl-L-proline 1(RS)-(1-trifluoroacetyl-2-methylpropyl)-amide | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1992-11-10 | — | — | US | claimed |
| US-5128322-A | Hemorrhage prevention after leukemia therapy | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1992-07-07 | — | — | US | claimed |
| JP-4235134-A | — | — | None | — | — | JP | disclosed |
| JP-4235133-A | — | — | None | — | — | JP | disclosed |
| JP-4243836-A | — | — | None | — | — | JP | disclosed |
| JP-4235132-A | — | — | None | — | — | JP | disclosed |
| EP-0762887-B1 | ACYLATED ENOL DERIVATIVES AS PRODRUGS OF ELASTASE INHIBITORS | MERRELL PHARMA INC (US) | 2001-09-26 | — | — | EP | disclosed |
| US-5972897-A | AN ANTIINFLAMMATORY AGENTS TREATING CYSTIC FIBROSIS AND EMPHYSEMA OR BOWEL DISEASES, A NEUTROPHIL ASSOCIATED INFLAMMATORY DISEASE, BRONCHITIS | MERRELL PHARMACEUTICALS INC. (US) | 1999-10-26 | — | — | US | disclosed |
| EP-0762887-A4 | ACYLATED ENOL DERIVATIVES AS PRODRUGS OF ELASTASE INHIBITORS | MERRELL PHARMA INC (US) | 1999-03-31 | — | — | EP | disclosed |
| JP-H04243836-A | ACUTE NON-LYMPHOCYTIC LEUKEMIA TREATING AGENT | IMPERIAL CHEM IND PLC <ICI> | 1992-08-31 | — | — | JP | disclosed |
| JP-H04235132-A | THERAPEUTIC PRODUCT FOR THE TREATMENT OF CYSTIC FIBROSIS | IMPERIAL CHEM IND PLC <ICI> | 1992-08-24 | — | — | JP | disclosed |
| JP-H04235134-A | THERAPEUTIC AGENT FOR TREATING ADULT RESPIRATORY DISTRESS SYNDROME | IMPERIAL CHEM IND PLC <ICI> | 1992-08-24 | — | — | JP | disclosed |
| JP-H04235133-A | COMPOUND FOR TREATMENT OF BRONCHITIS | IMPERIAL CHEM IND PLC <ICI> | 1992-08-24 | — | — | JP | disclosed |
| US-5128322-A | Hemorrhage prevention after leukemia therapy | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1992-07-07 | — | — | US | disclosed |
| EP-0463811-A3 | 4-(4-CHLOROPHENYLSULPHONYLCARBAMOYL)BENZOYL-L-VALYL-L-PROLINE-1-(RS)-(1-TRIFLUOROACETYL-2-METHYLPROPYL)AMIDE FOR TREATING HAEMORRHAGE ASSOCIATED WITH ACUTE NON-LYMPHOCYTIC LEUKAEMIA | — | 1992-04-01 | — | — | EP | disclosed |
| EP-0463811-A2 | 4-(4-Chlorophenylsulphonylcarbamoyl)benzoyl-L-valyl-L-proline-1-(RS)-(1-trifluoroacetyl-2-methylpropyl)amide for treating haemorrhage associated with acute non-lymphocytic leukaemia | ZENECA LIMITED (GB) | 1992-01-02 | — | — | EP | disclosed |